Co-Authors
This is a "connection" page, showing publications co-authored by Michael Busch and Mars Stone.
Connection Strength
3.961
-
Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations. Clin Infect Dis. 2021 01 27; 72(2):254-256.
Score: 0.926
-
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates. J Clin Microbiol. 2018 08; 56(8).
Score: 0.778
-
Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA. Transfusion. 2017 03; 57(3pt2):734-747.
Score: 0.704
-
Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program. Clin Infect Dis. 2021 Jun 10.
Score: 0.238
-
Piloting and implementation of quality assessment and quality control procedures in RBC-Omics: a large multi-center study of red blood cell hemolysis during storage. Transfusion. 2019 01; 59(1):57-66.
Score: 0.200
-
Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics. Clin Infect Dis. 2018 04 03; 66(8):1181-1183.
Score: 0.190
-
First cases of Zika virus-infected US blood donors outside states with areas of active transmission. Transfusion. 2017 03; 57(3pt2):770-778.
Score: 0.176
-
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment. mSphere. 2021 08 25; 6(4):e0048021.
Score: 0.060
-
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31).
Score: 0.060
-
SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance. Transfusion. 2021 09; 61(9):2677-2687.
Score: 0.059
-
Minipool testing for SARS-CoV-2 RNA in United States blood donors. Transfusion. 2021 08; 61(8):2384-2391.
Score: 0.059
-
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay. Transfusion. 2021 04; 61(4):1160-1170.
Score: 0.058
-
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques. Nat Commun. 2021 01 22; 12(1):541.
Score: 0.058
-
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nat Commun. 2021 01 04; 12(1):6.
Score: 0.058
-
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood. Nat Commun. 2020 09 17; 11(1):4698.
Score: 0.056
-
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. PLoS Comput Biol. 2019 04; 15(4):e1006849.
Score: 0.051
-
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests. Clin Infect Dis. 2017 Nov 13; 65(11):1829-1836.
Score: 0.046
-
Viral Surveillance in Serum Samples From Patients With Acute Liver Failure By Metagenomic Next-Generation Sequencing. Clin Infect Dis. 2017 Oct 16; 65(9):1477-1485.
Score: 0.046
-
Real-Time Evolution of Zika Virus Disease Outbreak, Roatán, Honduras. Emerg Infect Dis. 2017 08; 23(8):1360-1363.
Score: 0.046
-
Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study. Blood Adv. 2017 Jun 27; 1(15):1132-1141.
Score: 0.045
-
First Zika-positive donations in the continental United States. Transfusion. 2017 03; 57(3pt2):762-769.
Score: 0.044